Long-term impact of the low-FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability, and healthcare utilization in irritable bowel syndrome.
Study Goal
The researchers aimed to assess the long-term effectiveness of the low-FODMAP diet following FODMAP reintroduction in IBS patients.
Results Summary
The study found that the low-FODMAP diet provided satisfactory symptom relief in 61% of patients short-term and 57% long-term, with 82% continuing an adapted FODMAP diet. Nutritional adequacy was maintained, though the adapted FODMAP diet was costlier and affected social eating.
Population
Patients with irritable bowel syndrome (IBS).
Effective Dosage
Total FODMAP intake mean 20.6 g/d (adapted FODMAP) vs. 29.4 g/d (habitual).
Duration
Long-term follow-up after FODMAP reintroduction (exact duration not specified).
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
low-FODMAP diet | increase | satisfactory relief of symptoms | patients with IBS | 12% | satisfactory relief of symptoms was reported in | #1 |
low-FODMAP diet following FODMAP restriction (short term) | increase | satisfactory relief of symptoms | patients with IBS | 61% | satisfactory relief of symptoms was reported in | #2 |
low-FODMAP diet following FODMAP reintroduction (long term) | increase | satisfactory relief of symptoms | patients with IBS | 57% | satisfactory relief of symptoms was reported in | #3 |
'adapted FODMAP' diet | no change | diet adherence | patients with IBS | 84 (82%) patients | continued | #4 |
'adapted FODMAP' diet | neutral | total FODMAP intake | patients with IBS | 20.6, SD 14.9 g/d | total FODMAP intake mean | #5 |
'habitual' diet | no change | diet adherence | patients with IBS | 19 (18%) of patients | following | #6 |
'habitual' diet | neutral | total FODMAP intake | patients with IBS | 29.4, SD 22.9 g/d | total FODMAP intake mean | #7 |
low-FODMAP diet | no change | nutritional adequacy | patients with IBS | - | Nutritional adequacy was not compromised | #8 |
'adapted FODMAP' diet | increase | diet cost | patients with IBS | - | reported the diet cost significantly more | #9 |
'adapted FODMAP' diet | decrease | social eating | patients with IBS | - | affected social eating | #10 |
'adapted FODMAP' diet | no change | food-related QOL | patients with IBS | - | there was no effect on | #11 |
low-FODMAP diet | no change | healthcare utilization | patients with IBS | - | Healthcare utilization was similar | #12 |
Low-FODMAP education | increase | IBS management | patients with IBS | - | is effective for long-term IBS management | #13 |
Low-FODMAP education | increase | nutritional adequacy | patients with IBS | - | enables a nutritionally adequate diet | #14 |
Low-FODMAP education | increase | acceptability | patients with IBS | - | is broadly acceptable to patients | #15 |
BACKGROUND: The low-FODMAP diet is a frequently used treatment for irritable bowel syndrome (IBS). Most research has focused on short-term FODMAP restriction; however, guidelines recommend that high-FODMAP foods are reintroduced to individual tolerance. This study aimed to assess the long-term effectiveness of the low-FODMAP diet following FODMAP reintroduction in IBS patients. METHODS: Patients with IBS were prospectively recruited to a questionnaire study following completion of dietitian-led low-FODMAP education. At baseline and following FODMAP restriction (short term) only, gastrointestinal symptoms were measured as part of routine clinical care. Following FODMAP reintroduction, (long term), symptoms, dietary intake, acceptability, food-related quality of life (QOL), and healthcare utilization were assessed. Data were reported for patients who continued long-term FODMAP restriction (adapted FODMAP) and/or returned to a habitual diet (habitual). KEY RESULTS: Of 103 patients, satisfactory relief of symptoms was reported in 12% at baseline, 61% at short-term follow-up, and 57% at long-term follow-up. At long-term follow-up, 84 (82%) patients continued an 'adapted FODMAP' diet (total FODMAP intake mean 20.6, SD 14.9 g/d) compared with 19 (18%) of patients following a 'habitual' diet (29.4, SD 22.9 g/d, P=.039). Nutritional adequacy was not compromised for either group. The 'adapted FODMAP' group reported the diet cost significantly more than the 'habitual' group (P<.001) and affected social eating (P<.01) but there was no effect on food-related QOL. Healthcare utilization was similar between both groups. CONCLUSION AND INFERENCES: Low-FODMAP education is effective for long-term IBS management, enables a nutritionally adequate diet, and is broadly acceptable to patients.